Osman, Erkan Y.
Bolding, Madeline R.
Villalón, Eric
Kaifer, Kevin A.
Lorson, Zachary C.
Tisdale, Sarah
Hao, Yue http://orcid.org/0000-0002-5065-8906
Conant, Gavin C.
Pires, J. Chris http://orcid.org/0000-0001-9682-2639
Pellizzoni, Livio
Lorson, Christian L. http://orcid.org/0000-0002-1023-2169
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS102451)
Gwendolyn Strong Foundation
Article History
Received: 24 April 2019
Accepted: 11 June 2019
First Online: 1 July 2019
Competing Interests
: CLL is the co-founder and Chief Scientific Officer of Shift Pharmaceuticals.